Page last updated: 2024-10-30

6-anilino-5,8-quinolinedione and Cystic Fibrosis

6-anilino-5,8-quinolinedione has been researched along with Cystic Fibrosis in 1 studies

6-anilino-5,8-quinolinedione: structure given in first source; SRS-A & guanylate cyclase antagonist
6-anilino-5,8-quinolinedione : A quinolone that is quinoline-5,8-dione in which the hydrogen at position 6 is replaced by an anilino group.

Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, YJ1
Chao, AC1
Kouyama, K1
Hsu, YP1
Bocian, RC1
Moss, RB1
Gardner, P1

Other Studies

1 other study available for 6-anilino-5,8-quinolinedione and Cystic Fibrosis

ArticleYear
Activation of CFTR chloride current by nitric oxide in human T lymphocytes.
    The EMBO journal, 1995, Jun-15, Volume: 14, Issue:12

    Topics: Aminoquinolines; Arginine; CD4-Positive T-Lymphocytes; Chloride Channels; Clone Cells; Cyclic GMP; C

1995